U.S., Aug. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07786792) titled 'Biomarker and Mechanism Study of Systemic Therapy in Unresectable HCC' on Aug. 23.
Brief Summary: The goal of this observational study is to evaluate the safety and efficacy of systemic therapies and identify predictive molecular biomarkers in patients with intermediate to advanced stage or unresectable hepatocellular carcinoma (HCC).
The main questions it aims to answer are:What is the objective response rate (ORR) of systemic therapy regimens in this patient population? Which 3-4 specific biomarkers (including tumor or peripheral blood-derived genes, proteins, ctDNA, and immune cell subsets) can reliably predict the efficacy of s...